Heidi Crayton

1.6k total citations · 1 hit paper
12 papers, 1.0k citations indexed

About

Heidi Crayton is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Heidi Crayton has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 3 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in Heidi Crayton's work include Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (3 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (2 papers). Heidi Crayton is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (3 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (2 papers). Heidi Crayton collaborates with scholars based in United States, Switzerland and Australia. Heidi Crayton's co-authors include Howard Rossman, Patrick J. Oliverio, Evelyne T. Edwards, Thomas R. Cupps, Glenn D. Sandberg, Niveditha Mohan, John R. Richert, Jeffrey Siegel, Rock Heyman and Luigi Barbato and has published in prestigious journals such as Neurology, Frontiers in Immunology and Multiple Sclerosis Journal.

In The Last Decade

Heidi Crayton

12 papers receiving 976 citations

Hit Papers

Demyelination occurring during anti-tumor necrosis factor... 2001 2026 2009 2017 2001 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Demyelination occurring during anti-tumor necrosis factor ? therapy for inflammatory arthritides
    2001 613 citations Niveditha Mohan, Evelyne T. Edwards et al. Arthritis & Rheumatism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heidi Crayton United States 8 457 389 219 215 199 12 1.0k
Yann Mikaeloff France 10 461 1.0× 207 0.5× 273 1.2× 90 0.4× 126 0.6× 13 815
Antoine Guéguen France 16 236 0.5× 435 1.1× 244 1.1× 181 0.8× 163 0.8× 47 1.0k
Niveditha Mohan United States 8 164 0.4× 477 1.2× 122 0.6× 235 1.1× 172 0.9× 15 1.0k
Naila Makhani United States 16 859 1.9× 170 0.4× 264 1.2× 133 0.6× 98 0.5× 30 1.2k
Donald Brunet Canada 15 412 0.9× 178 0.5× 150 0.7× 267 1.2× 69 0.3× 25 932
Claire Hirst United Kingdom 15 900 2.0× 267 0.7× 374 1.7× 238 1.1× 102 0.5× 27 1.2k
Lilian T. L. Costallat Brazil 17 160 0.4× 585 1.5× 294 1.3× 194 0.9× 90 0.5× 33 875
Leszek Stawiarz Sweden 18 740 1.6× 266 0.7× 274 1.3× 122 0.6× 53 0.3× 35 1.0k
Amy Waldman United States 19 712 1.6× 205 0.5× 416 1.9× 81 0.4× 102 0.5× 57 1.1k
Uriel Katz Israel 15 170 0.4× 190 0.5× 123 0.6× 326 1.5× 261 1.3× 34 1.0k

Countries citing papers authored by Heidi Crayton

Since Specialization
Citations

This map shows the geographic impact of Heidi Crayton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Crayton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Crayton more than expected).

Fields of papers citing papers by Heidi Crayton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Crayton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Crayton. The network helps show where Heidi Crayton may publish in the future.

Co-authorship network of co-authors of Heidi Crayton

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Crayton. A scholar is included among the top collaborators of Heidi Crayton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Crayton. Heidi Crayton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Berkovich, Regina, et al.. (2025). Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series. Frontiers in Immunology. 16. 1527102–1527102. 1 indexed citations
2.
Dave, Rahul, et al.. (2024). COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review. Neurology and Therapy. 13(6). 1737–1745. 1 indexed citations
3.
Graham, Edith L., Riley Bove, Kathleen Costello, et al.. (2024). Practical Considerations for Managing Pregnancy in Patients With Multiple Sclerosis. Neurology Clinical Practice. 14(2). e200253–e200253. 5 indexed citations
4.
5.
González, Rafael Arroyo, Mariko Kita, Heidi Crayton, et al.. (2016). Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. 23(10). 1367–1376. 27 indexed citations
6.
7.
Fox, Edward, Keith R. Edwards, Daniel Wynn, et al.. (2014). Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis. Multiple Sclerosis and Related Disorders. 3(5). 607–619. 66 indexed citations
8.
9.
Crayton, Heidi & Howard Rossman. (2006). Managing the symptoms of multiple sclerosis: A multimodal approach. Clinical Therapeutics. 28(4). 445–460. 113 indexed citations
10.
Crayton, Heidi, Rock Heyman, & Howard Rossman. (2004). A multimodal approach to managing the symptoms of multiple sclerosis. Neurology. 63(11_suppl_5). S12–8. 97 indexed citations
11.
Wilken, Jeffrey, Robert L Kane, Mitchell T. Wallin, et al.. (2003). The utility of computerized neuropsychological assessment of cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. 9(2). 119–127. 57 indexed citations
12.
Mohan, Niveditha, Evelyne T. Edwards, Thomas R. Cupps, et al.. (2001). Demyelination occurring during anti-tumor necrosis factor ? therapy for inflammatory arthritides. Arthritis & Rheumatism. 44(12). 2862–2869. 613 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yann Mikaeloff Breakdown of academic impact, for papers by Antoine Guéguen Breakdown of academic impact, for papers by Niveditha Mohan Breakdown of academic impact, for papers by Naila Makhani Breakdown of academic impact, for papers by Donald Brunet Breakdown of academic impact, for papers by Claire Hirst Breakdown of academic impact, for papers by Lilian T. L. Costallat Breakdown of academic impact, for papers by Leszek Stawiarz Breakdown of academic impact, for papers by Amy Waldman Breakdown of academic impact, for papers by Uriel Katz
Rankless by CCL
2026